Light scatter-based immunoassay

• US 6,200,820 B1
• Filed: 06/07/1995
• Issued: 03/13/2001
• Est. Priority Date: 12/22/1992
• Status: Expired due to Fees

• Current Assignee: DiaSorin S.p.A.
• Original Assignee: Sienna Biotech, Inc.
• Inventors: Kochar, Manish, Edens, Carl Theodore, Hansen, W. Peter, Cennerazzo, Michael
• Primary Examiner(s): Le, Long V.
• Assistant Examiner(s): GRUN, JAMES LESLIE
• Application Number:
  US08/473,187
• Time in Patent Office: 2,106 Days
• Field of Search: 436/501, 436/518, 436/523, 436/525, 436/533, 436/164, 436/527, 436/534, 435/7.1, 435/6, 435/7.93, 435/7.94
• US Class Current: 436/523
• CPC Class Codes: G01N 15/0205 by optical means
• CPC Class Codes: G01N 15/14 Optical investigation techniques, e.g. flow cytometry
• CPC Class Codes: G01N 33/54346 Nanoparticles
• CPC Class Codes: G01N 33/553 Metal or metal coated

Abstract

Disclosed are an optical flow particle apparatus and method for conducting a particle light scatter-based immunoassay for simultaneously measuring the presence or amount of one or more analytes in a fluid sample which involves the use of a reagent set for each analyte including first binding molecule-coated monodisperse microspheres and second binding molecule-coated colloidal particles in which at least one of the first or second binding molecules specifically binds a respective one of the analytes. In the case where more than one analytes are detected, each monodisperse microperse microsphere of a particular reagent set has a light scatter signal resolvable from that of microspheres of any other reagent set. Changes determined in the distributions of the measured light scatter signals for individual microspheres of each of the particular reagent sets are indicative of the presence or amount of the respective analyte(s) in the sample.

Claims

1. A particle light scatter-based immunoassay for measuring an analyte in a fluid sample, comprising steps:

(a) combining with said fluid sample a reagent set including first binding molecule-coated monodisperse microspheres and second binding molecule-coated colloidal particles smaller than said microspheres, or an immunoconiplex comprising said monodisperse microspheres and said colloidal particles, to form a mixture and allow a reaction to occur wherein at least one of said first and second binding molecules binds said analyte, said reaction being formation or decomplexation of said immunocomplex, so that the reacted mixture includes microspheres in uncompleted form, in said immunocomplex, or both, wherein the degree of binding of said microspheres to the colloidal particles in the reacted mixture, or the degree of decomplexation of the immunocomplex, is dependent upon presence or amount of said analyte in said fluid sample;

(b) illuminating the reacted mixture with an incident light source to produce individual light scatter signals for each of said microspheres;

(c) measuring said light scatter signals;

(d) determining a degree of variation of a statistical distribution of the measured light scatter signals from said microspheres, such that the degree of variation of said statistical distribution varies with the degree of binding of said microspheres with said colloidal particles in said reacted mixture; and

(e) correlating said degree of variation of said statistical distribution of said light scatter signals for said microspheres in said reacted mixture with the presence or amount of said analyte in said fluid sample.

2. The method according to claim 1, wherein step (e) comprises correlating said degree of variation of said statistical distribution of said measurers light scatter signals with the amount of said analyte in said fluid sample.

3. The method according to claim 1, further comprising step of determining a statistical distribution of measured light scatter signals produced by a control.

4. The method according to claim 3, wherein said control comprises said first binding molecule-coated monodisperse microspheres.

5. The method according to claim 3, wherein said control comprises said immunocomplex.

6. The method according to claim 3, further comprising step (g) of normalizing the statistical distribution of said measured light scatter signals obtained in step (d) with respect to said control light scatter signal determination obtained in step (f).

7. The method according to claim 1, wherein said light scatter signals produced in said step (b) comprise low angle forward light scatter signals.

8. The method according to claim 1, wherein said light scatter signals produced in step (b) comprise forward light scatter signals from about 10°

to about 80°

.

9. The method according to claim 1, wherein said light scatter signals produced in step (b) comprise substantially right angle light scatter signals.

10. The method according to claim 1, wherein said light scatter signals produced in said step (b) comprise backscatter signals of from about 100°

to about 170°

.

11. The method according to claim 1, wherein said distribution is a distribution of amplitudes of the light scatter signals.

12. The method according to claim 11, wherein said distribution is a histogram of the amplitudes.

13. The method according to claim 1, wherein said distribution is a distribution of integrated areas of the light scatter signals.

14. The method according to claim 13, wherein said distribution is a histogram of the integrated areas.

15. The method according to claim 1, wherein said individual light scatter signals are produced for each of said microspheres by directing said incident light source onto each microsphere and monitoring light scattered therefrom and each individual light scatter signal is a ratio between an amplitude of light scattered at a low angle by the microsphere and an amplitude of light scattered at a high angle by the microsphere.

16. The method according to claim 1, wherein said distribution is a distribution of pulse width times maximum amplitude of the light scatter signals.

17. The method according to claim 16, wherein said distribution is a histogram of the pulse width times the maximum amplitude of the light scatter signals.

18. The method according to claim 1, wherein said illuminating is performed on a stream of the reacted mixture directed through an optical sheath flow particle analyzer comprising a sheath flow cell having a predetermined central bore diameter.

19. The method according to claim 18, wherein said predetermned central bore diameter is from about 100 μ

m to about 500 μ

m.

20. The method according to claim 19, wherein said predetermined central bore diameter is about 250 μ

m.

21. The method according to claim 18, wherein said stream has a substantially constant diameter.

22. The method according to claim 21, wherein said stream diameter is from about 3μ

to about 10μ

.

23. The method according to claim 1, wherein said incident light source is a laser light source.

24. The method according to claim 1, wherein said analyte is an antigen, antibody, hapten, nucleic acid or ligand.

25. The method according to claim 1, wherein said first binding molecule and said second binding molecule are complementary to said analyte.

26. The method according to claim 25, wherein said first binding molecule is an antibody specific to said analyte.

27. The method according to claim 25, wherein said second binding molecule is an antibody specific to said analyte.

28. The method according to claim 25, wherein said first binding molecule is a monoclonal antibody specific to said analyte.

29. The method according to claim 25, wherein said second binding molecule is a monoclonal antibody specific to said analyte.

30. The method according to claim 25, wherein said first binding molecule is a monoclonal antibody specific to a first epitope on said analyte, and said second binding molecule is a monoclonal antibody specific to a second epitope on said analyte.

31. The method according to claim 1, wherein said first binding molecule is said analyte.

32. The method according to claim 1, wherein said second binding molecule is complementary to said analyte.

33. The method according to claim 32, wherein said second binding molecule is an antibody specific to said analyte.

34. The method according to claim 33, wherein said antibody is a monoclonal antibody.

35. The method according to claim 1, wherein said monodisperse microspheres comprise a synthetic polymeric material.

36. The method according to claim 35, wherein said polymeric material comprises polybutadiene, polystyrene or a derivative thereof.

37. The method according to claim 1, wherein said monodisperse microspheres are glass microspheres.

38. The method according to claim 1, wherein said monodisperse microspheres comprise microscopic oxide powders.

39. The method according to claim 1, wherein said monodisperse microspheres have an average diameter of from about 0.25 μ

m to about 100 μ

m.

40. The method according to claim 39, wherein said average diameter is from about 0.25 μ

m to about 10 μ

m.

41. The method according to claim 39, wherein said average diameter is from about 0.5 μ

m to about 5.0 μ

m.

42. The method according to claim 1, wherein said colloidal particles are polydisperse.

43. The method according to claim 1, wherein said colloidal particles comprise a metal or a metal compound.

44. The method according to claim 43, wherein said metal compound is an oxide, hydroxide or a salt.

45. The method according to claim 43, wherein said metal is gold, platinum, silver or copper.

46. The method according to claim 45, wherein said metal is gold.

47. The method according to claim 1, wherein said colloidal particles have diameters ranging from about 20 nm to about 120 nm.

48. The method according to claim 47, wherein said diameters range from about 50 nm to about 80 nm.

49. The method according to claim 1, wherein said monodisperse microspheres have a first average diameter and said colloidal particles have a second average diameter, said first and second average diameters having a ratio of the average diameter of said monodisperse microspheres to the average diameter of said colloidal particles of from about 15:

1 to about 30;

1.

50. The method according to claim 1, wherein said colloidal particles and said monodisperse microspheres are present in said reagent set in a ratio effective to reduce interference by non-specific binding substances.

51. The method according to claim 50, wherein the ratio of said colloidal particles to said monodisperse microspheres is from about 2:

1 to about 100,000;

1.

52. The method according to claim 51 wherein said ratio is from about 1,000:

1 to about 10,000;

1.

53. The method according to claim 1, further comprising step (a′

) of separating the immunocomplex and the uncomplexed microspheres from the said reacted mixture prior to step (b) of illuminating and illuminating the immunocomplex separated from the reacted mixture in step (b) to produce said individual light scatter signals.

54. The method of claim 1, wherein diameters of said monodisperse microspheres have a coefficient of variation less than 5%.

55. The method of claim 1, wherein diameters of said monodisperse microspheres have a coefficient of variation of from about 1% to about 2%.

56. The method of claim 1, wherein diameters of said monodisperse microspheres have a coefficient of variation less than 2%.

57. A particle light scatter-based immunoassay for simultaneously measuring more than one analyte in a fluid sample, comprising steps:

(a) combining with said fluid sample for each said more than one analyte, a reagent set including first binding molecule-coated monodisperse microspheres and second binding molecule-coated colloidal particles smaller than said microspheres, or an immunocomplex comprising said monodisperse microspheres and said colloidal particles, to form a mixture of fluid sample and all reagent sets together and allow a reaction to occur wherein at least one of said first and second binding molecules of each said reagent set binds a respective one of said more than one analyte, said reaction being formation or decomplexation of each said immunocomplex, so that the reacted mixture includes microspheres of each said reagent set in uncomplexed form, in said immunocomplex, or both, wherein the degree of binding of said microspheres to the colloidal particles of each said reagent set in the reacted mixture, or the degree of decomplexation of each said immunocomplex, is dependent upon presence or amount of each said more than one analyte in said fluid sample;

(b) illuminating the reacted mixture with an incident light source to produce individual light scatter signals for each of said microspheres wherein the light scatter signals produced for the microspheres of each said reagent set are resolvable from the light scatter signals produced for the microspheres of any other said reagent set;

(c) measuring said light scatter signals;

(d) determining a degree of variation of a statistical distribution of the measured light scatter signals from said microspheres of each said reagent set, such that the degree of variation of said statistical distribution varies with the degree of binding of said microspheres with said colloidal particles of each said reagent set in said reacted mixture; and

(e) correlating said degree of variation of eh said statistical distribution of said light scatter signals for said microspheres in said reacted mixture with the presence or amount of each respective one of said more than one analyte in said fluid sample.